More on Conmed Q1 Results

• Revenues were $181.9M (-2.7%), EPS: $0.31 (-19.4%).
• International sales: $94.6M.
• EBITDA yield was 15.4%.
• CF Ops: $17M (+214.8%).
• Q2 guidance:
• Revenues: $190M - $195M.
• EPS: $0.44 - $0.48.
• 2014 guidance:
• Revenues: $770M - $780M.
• EPS: $1.90 - $2.00.
• Guidance excludes special items related to the relocation of manufacturing, litigation and other costs.
• (NASDAQ:CNMD)